{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT04435691: Phase 1/Phase 2 Interventional Active, not recruiting Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04210245: Phase 2 Interventional Completed Compensated Cirrhosis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03039686: Phase 2/Phase 3 Interventional Completed Duchenne Muscular Dystrophy
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04535674: Phase 2 Interventional Completed COVID-19 Induced Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03694522: Phase 2 Interventional Completed Gastric Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04587830: Phase 2 Interventional Recruiting Glioblastoma Multiforme (GBM)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03290781: Phase 3 Interventional Completed Ulcerative Colitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04023526: Phase 2 Interventional Active, not recruiting Leukemia, Myeloid, Acute
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02573467: Phase 3 Interventional Completed Sporadic Inclusion Body Myositis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01188681: Phase 1/Phase 2 Interventional Completed Chronic Lymphocytic Leukemia (CLL)
(2010)
Source URL:
Class:
PROTEIN
